Results 221 to 230 of about 1,722,968 (253)

Outcomes of allogeneic haemopoietic transplant for chronic lymphocytic leukaemia in the modern era. [PDF]

Intern Med J
Barge L, Tran S, Kennedy G, Ritchie D, Gottlieb D, Milliken S, Spencer A, Purtill D, Perera T, Doocey R, Larsen S, Butler A, Bardy P, Greenwood M, Durrant S, Curley C, Stewart C, Tam C, Balendran S, Di Ciaccio PR, Patil S, Han MH, Hamad N.   +22 more
europepmc   +1 more source

Venous Thromboembolism in Hematologic Malignancies: Incidence, Risk Factors, and the Role of Direct Oral Anticoagulants

European Journal of Haematology, EarlyView.
ABSTRACT Thrombotic events, particularly venous thromboembolism (VTE), are a significant source of morbidity and mortality among patients with hematologic malignancies. These patients face unique challenges due to treatment‐related complications such as thrombocytopenia, coagulopathy, and heightened bleeding risk.
Mario Biglietto, Silvia Sorella, Erminia Baldacci, Massimo Breccia, Sabina Chiaretti, Marcello Capriata, Livia Donzelli, Gianna Maria D'Elia, Salvatore Giacomo Morano, Ilaria Del Giudice, Maurizio Martelli, Cristina Santoro, Antonio Chistolini   +12 more
wiley   +1 more source

Should the current diagnostic criteria for CLL be reconsidered? A reply to Johnstone et al. "De-diagnosing chronic lymphocytic leukaemia: An ethical and scientific case for changing diagnostic criteria". [PDF]

Hemasphere
Matos DM.
europepmc   +1 more source

Economic Burden of Chronic Lymphocytic Leukaemia in Australia

European Journal of Haematology, EarlyView.
ABSTRACT Background The treatment landscape for chronic lymphocytic leukaemia (CLL) has transformed over the past decade. This study aimed to estimate the healthcare costs and health burden associated with CLL in Australia. Methods A Markov model was developed to simulate the lifetime healthcare costs and health outcomes associated with CLL in ...
Lan Gao, Dieu Nguyen, Victoria White, Patricia M. Livingston, Chan Y. Cheah   +4 more
wiley   +1 more source

Matching-adjusted indirect comparisons of efficacy and safety for zanubrutinib versus the combination of fixed-duration venetoclax and ibrutinib in patients with treatment-naïve chronic lymphocytic leukaemia. [PDF]

Br J Haematol
Munir T, Mohseninejad L, Rakonczai P, Dobi B, Xu S, Yang K, Vezan R, Calle NM.   +7 more
europepmc   +1 more source

Simultaneous occurrence of chronic lymphocytic leukaemia and acute lymphoblastic leukaemia

Haematologica, 2002
J Bueno, MD Irriguible, C Palacio
doaj  

A comprehensive analysis of pirtobrutinib in Chinese patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL): Results from the phase 3 study BRUIN CLL-321. [PDF]

Br J Haematol
Yi S, Cao J, Feng R, Zhou K, Qiu L, Li F, Yang HY, Zhou H, Hui W, Cui J, Huang H, Zhu J, Ye X, Sharman J, Qiu L.   +14 more
europepmc   +1 more source

Individualised but Specific Exercise Training Improves Physiologic Reserve and Reduces Frailty in Older Adults with Chronic Lymphocytic Leukaemia: A 12-Week Pragmatic Randomised Controlled Trial

Miles EE, Hulton AT, Jeary C, Li L, Fielding B, Zaheer U, Manders R, Stratton E, Walewska R, Iyengar S, Hanson ED, Sitlinger A, Bartlett DB.   +12 more
europepmc   +1 more source

The unfolded protein response influences therapy outcome and disease progression in chronic lymphocytic leukaemia. [PDF]

Sci Rep
Khan UT, Clarke K, Eagle G, Oates M, Hillmen P, Jayne S, Dyer MJS, Phipps A, Falciani F, Jenkins RE, Pettitt AR.   +10 more
europepmc   +1 more source

CD19 CAR T-Cell Therapy in Richter Transformation: A Multicentre Retrospective Analysis by the European Research Initiative on Chronic Lymphocytic Leukaemia. [PDF]

J Cell Mol Med
Beyar-Katz O, Benjamini O, Delgado J, Ruella M, Ram R, Grisariu S, Visentin A, Vandenberghe E, Gentile M, Avigdor A, Shimoni A, Shouval R, Marcus R, Schuster SJ, Ortiz-Maldonado V, Ghilardi G, Paruzzo L, Zuckerman T, Tadmor T, Fineman R, Amit O, Martinez-Cibrian N, Gabrielli G, Avni B, Minga E, Shem-Tov N, Scarfo L, Yerushalmi R, Nagler A, Leiba R, Danylesko I, Stamatopoulos K, Chatzikonstantinou T, Ghia P, Herishanu Y.   +34 more
europepmc   +1 more source